3 Health Services Stocks On The Rise

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 22 points (0.1%) at 16,756 as of Friday, June 13, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,558 issues advancing vs. 1,369 declining with 183 unchanged.

The Health Services industry currently sits down 0.3% versus the S&P 500, which is up 0.2%. A company within the industry that increased today was Waters ( WAT), up 0.6%. On the negative front, top decliners within the industry include WuXi PharmaTech (Cayman ( WX), down 4.6%, Bruker ( BRKR), down 1.9%, Grifols ( GRFS), down 1.1%, CR Bard ( BCR), down 1.0% and Smith & Nephew ( SNN), down 0.9%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Universal Health Services ( UHS) is one of the companies pushing the Health Services industry higher today. As of noon trading, Universal Health Services is up $0.97 (1.1%) to $93.47 on light volume. Thus far, 225,946 shares of Universal Health Services exchanged hands as compared to its average daily volume of 799,800 shares. The stock has ranged in price between $92.34-$93.61 after having opened the day at $92.59 as compared to the previous trading day's close of $92.50.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. Universal Health Services has a market cap of $8.5 billion and is part of the health care sector. Shares are up 13.8% year-to-date as of the close of trading on Thursday. Currently there are 11 analysts who rate Universal Health Services a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Universal Health Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Universal Health Services Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Community Health Systems ( CYH) is up $0.73 (1.7%) to $43.24 on average volume. Thus far, 792,513 shares of Community Health Systems exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $42.24-$43.32 after having opened the day at $42.80 as compared to the previous trading day's close of $42.51.

Community Health Systems, Inc., together with its subsidiaries, provides general and specialized hospital healthcare services to patients in the United States. Community Health Systems has a market cap of $5.0 billion and is part of the health care sector. Shares are up 8.2% year-to-date as of the close of trading on Thursday. Currently there are 12 analysts who rate Community Health Systems a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Community Health Systems as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Community Health Systems Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Boston Scientific ( BSX) is up $0.07 (0.5%) to $12.87 on average volume. Thus far, 6.0 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 11.9 million shares. The stock has ranged in price between $12.76-$12.94 after having opened the day at $12.79 as compared to the previous trading day's close of $12.80.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. Boston Scientific has a market cap of $17.0 billion and is part of the health care sector. Shares are up 6.5% year-to-date as of the close of trading on Thursday. Currently there are 11 analysts who rate Boston Scientific a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, good cash flow from operations and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Boston Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%